Effectiveness of 13-valent pneumococcal conjugate vaccine on radiological primary end-point pneumonia among cases of severe community acquired pneumonia in children: A prospective multi-site hospital-based test-negative study in Northern India

Effectiveness of 13-valent pneumococcal conjugate vaccine on radiological primary end-point pneumonia among cases of severe community acquired pneumonia in children: A prospective multi-site hospital-based test-negative study in Northern India

Show other versions (1)

<h4>Introduction</h4> Community acquired pneumonia (CAP) is a leading cause of under-five mortality in India and Streptococcus pneumoniae is the main bacterial pathogen for it. Pneumococcal Conjugate Vaccine 13 (PCV13) has been introduced in a phased manner, in the national immunization...

Full description

Bibliographic Details
Main Authors: Shally Awasthi, Neera Kohli, Monika Agarwal, Chandra Mani Pandey, Tuhina Rastogi, Anuj Kumar Pandey, Chittaranjan Roy, Kripanath Mishra, Neelam Verma, Chandra Bhushan Kumar, Pankaj Kumar Jain, Rajesh Yadav, Puneet Dhasmana, Abhishek Chauhan, Namita Mohindra, Ram Chandra Shukla
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9754232/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9754232/?tool=EBI

Similar Items